Most of the buzz surrounding the Giants this winter has involved the team’s pursuits of position players or rotation help, yet the bullpen stands out as a significant need for the team since Randy Rodriguez will miss the 2026 season due to Tommy John surgery. San Francisco signed Sam Hentges and got involved in Devin Williams’ market before Williams signed with the Mets, though as with the roster as a whole, not much has yet been done during what has been a quiet Giants offseason.
Susan Slusser of the San Francisco Chronicle took a look at some of the available relievers that might help upgrade the bullpen, and also added the new information that “the Giants have been in touch with” Michael Kopech. The right-hander is an interesting buy-low candidate for the Giants or many other teams, as Kopech is coming off an injury-shortened 2025 campaign.
Three separate placements on the injured list limited Kopech to 11 regular-season innings with the Dodgers, and he didn’t pitch for L.A. during its postseason run. Kopech was twice placed on the 60-day IL due to a shoulder impingement and meniscus surgery, and he then finished the season on the 15-day IL due to a recurrence of his right knee discomfort. He did deliver a 2.45 ERA and 22.6% strikeout rate during his small chunk time on the mound this year, but with the huge red flag of a 24.5% walk rate, as Kopech had more walks (13) than strikeouts (12) over his 11 frames.
Kopech was once one of baseball’s most highly-regarded pitching prospects, and was a significant piece of the trade package the White Sox acquired from the Red Sox in the Chris Sale deal in December 2016. He made his MLB debut in 2018 but then didn’t pitch in either of the next two seasons, due to a Tommy John surgery and Kopech’s decision to opt out of the pandemic-shortened 2020 campaign. He eased his way back into action by working primarily as a reliever in 2021, and had decent numbers in a full-time starting role in 2022 while battling more injuries.
Control problems and home runs started to become an overwhelming issue for Kopech in 2023, and the White Sox decided to move him to the bullpen the following season in an effort to both combat these issues and keep him healthy. Kopech’s walk rate was still on the high side, but he finally seemed to put things together after a deadline trade to the Dodgers. The righty posted a 1.13 ERA over 24 regular-innings with Los Angeles and then had a 3.00 ERA over nine postseason frames to help the Dodgers win the 2024 World Series.
Kopech is just entering his age-30 season, and he averaged 97.5mph on his fastball in 2025. The strikeout potential and pure stuff in Kopech’s arsenal provides hope that he can still develop into a consistent bullpen weapon, if he can stay healthy and keeps the walks even somewhat in check. A one-year contract seems like the max for Kopech in the wake of his more-or-less lost season, yet that scenario probably works fine for the righty and agent Scott Boras — a strong 2026 season would very likely set Kopech up nicely for a more lucrative longer-term contract next winter.
New Giants bullpen coach Jesse Chavez briefly crossed paths with Kopech when Chavez spent Spring Training 2024 in Chicago’s camp on a minor league contract. Who knows if that brief stint as teammates might give San Francisco any edge in signing Kopech, but perhaps more importantly, the Giants can offer Kopech plenty of opportunity within a pretty wide-open bullpen picture. It isn’t a reach to imagine that an in-form Kopech could quickly earn high-leverage work, and he did amass 15 saves for the White Sox and Dodgers in 2024.
